Pilot Study of Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia with Deep Molecular Response (EDI-PIO) - Evaluation of Pioglitazone in Treatment-Free Remission

被引：0
|
作者：
Pagnano, Katia B.
Miranda, Eliana C.
Delamain, Marcia Torresan
Duarte, Gislaine Oliveira
Virgilio, Bruna
Vianna, Jessica
De Paula, Erich Vinicius
De Souza, Carmino Antonio
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1595
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Kimura, Shinya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e138 - e141
  • [22] Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial
    Kim, Dennis D. H.
    Novitzky-Basso, Igor
    Kim, Taehyung S.
    Atenafu, Eshetu G.
    Forrest, Donna
    Savoie, Lynn
    Bence-Bruckler, Isabelle
    Keating, Mary-Margaret
    Busque, Lambert
    Delage, Robert
    Xenocostas, Anargyros
    Liew, Elena
    Paulson, Kristjan
    Stockley, Tracy
    Laneuville, Pierre
    Lipton, Jeffrey H.
    Kamel-Reid, Suzanne
    Leber, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (04) : 779 - 791
  • [23] Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial
    Kim, Dennis Dong Hwan
    Novitzky-Basso, Igor Nicolas
    Kim, Taehyung
    Atenafu, Eshetu G.
    Savoie, Lynn
    Bence-Bruckler, Isabelle
    Forrest, Donna L.
    Busque, Lambert
    Delage, Robert
    Xenocostas, Anargyros
    Keating, Mary-Margaret
    Liew, Elena
    Paulson, Kristjan
    Stockley, Tracy L.
    Laneuville, Pierre
    Lipton, Jeffrey H.
    Kamel-Reid, Suzanne
    Leber, Brian
    BLOOD, 2020, 136
  • [24] DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients
    Malighetti, Federica
    Arosio, Giulia
    Manfroni, Chiara
    Mauri, Mario
    Villa, Matteo
    Manghisi, Beatrice
    Inzoli, Elena
    Rindone, Giovanni
    Zambrotta, Giovanni P. M.
    Civettini, Ivan
    Guglielmana, Veronica
    Ramazzotti, Daniele
    Giudici, Giovanni
    Bombelli, Silvia
    Perego, Roberto
    Piazza, Rocco
    Mologni, Luca
    Gambacorti-Passerini, Carlo
    HEMASPHERE, 2023, 7 (03):
  • [25] The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort
    Saugues, Sandrine
    Lambert, Celine
    Daguenet, Elisabeth
    Roth-Guepin, Gabrielle
    Huguet, Francoise
    Cony-Makhoul, Pascale
    Ansah, Hyacinthe Johnson
    Escoffre-Barbe, Martine
    Turhan, Ali
    Rousselot, Philippe
    Tchirkov, Andrei
    Hamroun, Dalil
    Hermet, Eric
    Pereira, Bruno
    Berger, Marc G.
    HAEMATOLOGICA, 2024, 109 (09) : 2893 - 2907
  • [26] Treatment-Free Remission (TFR) in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) and in Stable Deep Molecular Response (DMR) to Dasatinib - the Dasfree Study
    Shah, Neil P.
    Paquette, Ronald
    Mueller, Martin C.
    Saussele, Susanne
    Garcia-Gutierrez, Valentin
    Jimenez-Velasco, Antonio
    Nicolini, Franck-Emmanuel
    Mauro, Michael J.
    Mahon, Francois-Xavier
    Rea, Delphine
    Martin-Regueira, Patricia
    Subar, Milayna
    Li, Li
    Lipton, Jeffrey H.
    BLOOD, 2016, 128 (22)
  • [27] TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND LONG THERAPEUTIC DURATION
    Estaben Irene, Rivas
    Lopez Alicia, Ortiz
    Jose Manuel, Vinuesa Hernando
    Vazquez Sonia, Angos
    Ortiz Natalia, Gemperle
    Arruga Elena, Bonafonte
    Maria Aranzazu, Alcacera Lopez
    Maria Victoria, Dourdil Sahun
    Lazaro Beatriz, Martinez
    Jose Antonio, Moreno Chulilla
    Bernal Luis, Palomera
    HAEMATOLOGICA, 2021, 106 (10) : 255 - 255
  • [28] Economic Impact Analysis of Treatment-Free Remission in Chronic Myeloid Leukemia Patients with Sustained Deep Molecular Response in the AST-2018 Trial
    Khalil Tannuri, Ricardo Khalil
    Moiraghi, Beatriz
    Arturo Paylovsky, Miguel
    Varela, Ana Ines
    Bianchini, Michele
    Giere, Isabel
    Fernandez, Isolda I.
    Bendek, Georgina
    Mariano, Romina
    Freitas, Josefina
    Ventriglia, Veronica
    Del Rosario Custidiano, Maria
    Garcia de Labanca, Ana
    Sanchez Avalos, Julio Cesar
    Mela Osorio, Maria J.
    Vasconcelos Cordoba, Bianca
    Belen Sanchez, Maria
    Juni, Mariana
    Bianco, Marcos
    Pavlovsky, Carolina
    BLOOD, 2022, 140 : 5088 - 5089
  • [29] Chronic myeloid leukemia patients and treatment-free remission attitudes: a multicenter survey
    Lou, Jin
    Huang, Junjie
    Wang, Zitong
    Wen, Bingbing
    Tu, Chuanqing
    Huang, Wangxiang
    Zhai, Zhimin
    Du, Xin
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1025 - 1032
  • [30] Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission
    Dulucq, Stephanie
    Hayette, Sandrine
    Cayuela, Jean-Michel
    Bauduer, Frederic
    Chabane, Kaddour
    Chevallier, Patrice
    Cony-Makhoul, Pascale
    Flandrin-Gresta, Pascale
    Le Jeune, Caroline
    Le Bris, Yannick
    Legros, Laurence
    Maisonneuve, Herve
    Roy, Lydia
    Mahon, Francois-Xavier
    Sloma, Ivan
    Rea, Delphine
    Nicolini, Franck Emmanuel
    HAEMATOLOGICA, 2022, 107 (12) : 2944 - 2949
12345